318 related articles for article (PubMed ID: 38487541)
1. New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era.
Hu X; Chen S; Ye S; Chen W; Zhou Y
Front Immunol; 2024; 15():1342837. PubMed ID: 38487541
[TBL] [Abstract][Full Text] [Related]
2. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
Zheng W; Guo J; Liu ZS
Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
[TBL] [Abstract][Full Text] [Related]
3. Effects of Zhuang medicine compound Xiancao Granule on diabetic kidney disease: A multi-omics analysis.
Mo C; Zhao J; Liang J; Chen Y; Wang H; Dai Y; Huang G
J Ethnopharmacol; 2024 Mar; 321():117517. PubMed ID: 38042391
[TBL] [Abstract][Full Text] [Related]
4. Diabetic kidney diseases revisited: A new perspective for a new era.
Fu H; Liu S; Bastacky SI; Wang X; Tian XJ; Zhou D
Mol Metab; 2019 Dec; 30():250-263. PubMed ID: 31767176
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease.
Mitrofanova A; Fontanella AM; Burke GW; Merscher S; Fornoni A
Cells; 2022 Nov; 11(22):. PubMed ID: 36429063
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
Kato M; Natarajan R
Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700
[TBL] [Abstract][Full Text] [Related]
7. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
Hasegawa S; Inagi R
Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
Guo J; Liu Z; Gong R
Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
[TBL] [Abstract][Full Text] [Related]
10. A Systems Nephrology Approach to Diabetic Kidney Disease Research and Practice.
Martin WP; Docherty NG
Nephron; 2024; 148(3):127-136. PubMed ID: 37696257
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience.
Downie ML; Desjarlais A; Verdin N; Woodlock T; Collister D
Can J Kidney Health Dis; 2023; 10():20543581231209012. PubMed ID: 37920777
[TBL] [Abstract][Full Text] [Related]
12. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review.
Das S; Devi Rajeswari V; Venkatraman G; Elumalai R; Dhanasekaran S; Ramanathan G
Transl Res; 2024 Mar; 265():71-87. PubMed ID: 37952771
[TBL] [Abstract][Full Text] [Related]
13. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.
Pichler R; Afkarian M; Dieter BP; Tuttle KR
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F716-F731. PubMed ID: 27558558
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.
Jung CY; Yoo TH
Diabetes Metab J; 2022 Mar; 46(2):181-197. PubMed ID: 35385633
[TBL] [Abstract][Full Text] [Related]
15. Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease.
Stanton RC
Curr Diab Rep; 2021 Jan; 21(2):6. PubMed ID: 33449215
[TBL] [Abstract][Full Text] [Related]
16. What's New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances.
Watanabe K; Sato E; Mishima E; Miyazaki M; Tanaka T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614011
[TBL] [Abstract][Full Text] [Related]
17. Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression.
Youssef N; Noureldein MH; Riachi ME; Haddad A; Eid AA
Am J Physiol Renal Physiol; 2024 Mar; 326(3):F301-F312. PubMed ID: 38153850
[TBL] [Abstract][Full Text] [Related]
18. Targeting inflammation to treat diabetic kidney disease: the road to 2030.
Rayego-Mateos S; Rodrigues-Diez RR; Fernandez-Fernandez B; Mora-Fernández C; Marchant V; Donate-Correa J; Navarro-González JF; Ortiz A; Ruiz-Ortega M
Kidney Int; 2023 Feb; 103(2):282-296. PubMed ID: 36470394
[TBL] [Abstract][Full Text] [Related]
19. Complement Cascade Proteins Correlate with Fibrosis and Inflammation in Early-Stage Type 1 Diabetic Kidney Disease in the Ins2Akita Mouse Model.
Tserga A; Saulnier-Blache JS; Palamaris K; Pouloudi D; Gakiopoulou H; Zoidakis J; Schanstra JP; Vlahou A; Makridakis M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338666
[TBL] [Abstract][Full Text] [Related]
20. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
